Evidence map›Paper›PMID 17606295›Full record

ArticleMolecular immunology2008

Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes.

Tamara K Nowling, Jennifer Dziadyk Fulton, Katherine Chike-Harris, Gary S Gilkeson

Open access · bronzeAbstract read
In one paragraph

Article in Molecular immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. T cell Metabolism in Lupus.Immunometabolism · 2020
    Article
  5. Article
  6. Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis.Journal of the American Society of Nephrology : JASN · 2015
    Article
  7. Review
  8. RUNX3 facilitates growth of Ewing sarcoma cells.Journal of cellular physiology · 2014
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tamara K NowlingDepartment of Medicine, Division of Rheumatology, Medical University of South Carolina, 96 Jonathan Lucas Street, Ste 912 CSB, Charleston, SC 29425, USA. nowling@musc.edu
Jennifer Dziadyk Fulton
Katherine Chike-Harris
Gary S Gilkeson
Medical University of South Carolina · US

Funding

ROLE OF PPAR GAMMA IN LUPUS NEPHRITISR01AR047451 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GILKESON, GARY S. · 2001 to 2005
$1.2M
Regulation of Fli1 gene expression in lupusK01DK072306 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI NOWLING, TAMMY (TAMARA) · 2005 to 2008
$345k
NIAMS NIH HHS AR47451NIAMS NIH HHS R01 AR047451NIDDK NIH HHS DK072306NIDDK NIH HHS K01 DK072306
6 · The paper itself

Abstract

Fli1 is an Ets family member that is essential for embryonic development. Increasing evidence suggests modulating Fli1 gene expression impacts lymphocyte development/function and is an important mediator in the autoimmune disease lupus. Fli1 is over-expressed in splenic lymphocytes in lupus prone mouse strains and in PBMCs of lupus patients. Presently, it is unknown how Fli1 gene expression is controlled in lymphocytes or how it becomes over-expressed in lupus. Therefore, we examined Fli1 regulation in a murine B cell line and T cell line and identified several cis-regulatory elements within a 230 bp region that contribute to Fli1 promoter activity. Ets factors Elf1, Tel and Fli1 bind in vitro to this region and increase endogenous Fli1 expression when over-expressed in a T cell line. In addition, we determined that a microsatellite located adjacent to the region containing these cis-regulatory elements is polymorphic in three lupus prone mouse strains and that the length of the microsatellite is inversely correlated with promoter activity in a T cell line. These results suggest that several Ets factors, including Fli1 itself, are involved in the transcriptional regulation of Fli1 in lymphocytes. Furthermore, the presence of a polymorphic microsatellite in the Fli1 promoter may contribute to increased Fli1 expression in T cells during lupus disease progression.

Indexed as

Polymorphism, GeneticAnimalsBase SequenceBinding SitesB-LymphocytesCell LineDisease Models, AnimalDNA-Binding ProteinsDNA Mutational AnalysisDown-RegulationETS Translocation Variant 6 ProteinGATA Transcription FactorsLymphocytesMiceMice, Inbred BALB CMicrosatellite RepeatsDNA-Binding ProteinsElf1 protein, mouseETS Translocation Variant 6 ProteinGATA Transcription FactorsNuclear ProteinsProto-Oncogene Protein c-fli-1Proto-Oncogene Proteins c-etsRepressor ProteinsSTAT Transcription FactorsTranscription Factors

Identifiers

PMID17606295
PMCPMC2045641
OpenAlexW2065031778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.